Magnetic Resonance Spectroscopic Imaging (¹H-MRSI) and Dynamic Contrast-Enhanced Magnetic Resonance (DCE-MRI): Pattern Changes From Inflammation to Prostate Cancer

REFERENCES

• Sciarra, A.; Di Silverio, F.; Salciccia, S.; Autran Gomez, A.M.; Gentilucci, A.; Gentile, V. Inflammation and chronic prostatic diseases: evidence for a link? Eur Urol 2007 Oct, 52(4), 964–972.
   PubMed Web of Science ®Google Scholar
• Dennis, L.K.; Lynch, C.F.; Torner, J.C. Epidemiologic association between prostatitis and prostate cancer. Urology 2002 Jul, 60(1), 78–83.
   PubMed Web of Science ®Google Scholar
• Nelson, W.G.; De Marzo, A.M.; Isaacs, W.B. Prostate cancer. N Engl J Med 2003 Jul 24, 349(4), 366–381.
   PubMed Web of Science ®Google Scholar
• Naber, K.G.; Weidner, W. Chronic prostatitis-an infectious disease? J Antimicrob Chemother 2000 Aug, 46(2), 157–161.
   PubMed Web of Science ®Google Scholar
• Wagenlehner, F.M.E.; Elkahwaji, J.E.; Algaba, F.; Bjerklund-Johansen, T.; Naber, K.G.; Hartung, R.; Weidner, W. The role of inflammation and infection in the pathogenesis of prostate carcinoma. BJU Int 2007 Oct, 100(4), 733–737.
   PubMed Web of Science ®Google Scholar
• De Marzo, A.M.; Marchi, V.L.; Epstein, J.I.; Nelson, W.G. Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis. Am J Pathol 1999 Dec, 155(6), 1985–1992.
   PubMed Web of Science ®Google Scholar
• Okada, K.; Kojima, M.; Naya, Y.; Kamoi, K.; Yokoyama, K.; Takamatsu, T.; Miki, T. Correlation of histological inflammation in needle biopsy specimens with serum prostate-specific antigen levels in men with negative biopsy for prostate cancer. Urology 2000 Jun, 55(6), 892–898.
   PubMed Web of Science ®Google Scholar
• Mazaheri, Y.; Shukla-Dave, A.; Hricak, H.; Fine, S.W.; Zhang, J.; Inurrigarro, G.; Moskowitz, C.S.; Ishill, N.M.; Reuter, V.E.; Touijer, K.; Zakian, K.L.; Koutcher, J.A. Prostate cancer: identification with combined diffusion-weighted MR imaging and 3D 1H MR spectroscopic imaging-correlation with pathologic findings. Radiology 2008 Feb, 246(2), 480–488.
   PubMed Web of Science ®Google Scholar
• Jager, G.J.; Ruijter, E.T.; van de Kaa, C.A.; de LaRosette, J.J.; Oosterhof, G.O.; Thornbury, J.R.; Ruijs, S.H.; Barentsz, J.O. Dynamic TurboFLASH subtraction technique for contrast-enhanced MR imaging of the prostate: correlation with histopathologic results. Radiology 1997, 203, 645–652.
   PubMed Web of Science ®Google Scholar
• Sciarra, A.; Salciccia, S.; Panebianco, V. Proton spectroscopic and dynamic contrast-enhanced magnetic resonance: a modern approach in prostate cancer imaging. Eur Urol 2008, 54(3), 485–488.
   PubMed Web of Science ®Google Scholar
• Kumar, R.; Nayyar, R.; Kumar, V.; Gupta, N.P.; Hemal, A.K.; Jagannathan, N.R.; Dattagupta, S.; Thulkar, S. Potential of magnetic resonance spectroscopic imaging in predicting absence of prostate cancer in men with serum prostate-specific antigen between 4 and 10 ng/mL: a follow-up study. Urology 2008, 72(4) 859–863.
   PubMed Web of Science ®Google Scholar
• Mullerad, M.; Hricak, H.; Kuroiwa, K.; Pucar, D.; Chen, H.N.; Kattan, M.W.; Scardino, P.T. Comparison of endorectal magnetic resonance imaging, guided prostate biopsy and digital rectal examination in the preoperative anatomical localization of prostate cancer. J Urol 2005 Dec, 174(6), 2158–2163.
   PubMed Web of Science ®Google Scholar
• Hom, J.J.; Coakley, F.V.; Simko, J.P.; Lu, Y.; Qayyum, A.; Westphalen, A.C.; Schmitt, L.D.; Carroll, P.R.; Kurhanewicz, J. High-grade prostatic intraepithelial neoplasia in patients with prostate cancer: MR and MR spectroscopic imaging features—initial experience. Radiology 2007 Feb, 242(2), 483–489.
   PubMed Web of Science ®Google Scholar
• Zakian, K.L.; Sircar, K.; Hricak, H.; Chen, H.N.; Shukla-Dave, A.; Eberhardt, S.; Muruganandham, M.; Ebora, L.; Kattan, M.W.; Reuter, V.E.; Scardino, P.T.; Koutcher, J.A. Correlation of proton MR spectroscopic imaging with gleason score based on step-section pathologic analysis after radical prostatectomy. Radiology 2005 Mar, 234(3), 804–814.
   PubMed Web of Science ®Google Scholar
• Jager, G.J.; Ruijter, E.T.; van de Kaa, C.A.; de la Rosette, J.J.; Oosterhof, G.O.; Thornbury, J.R.; Ruijs, S.H.; Barentsz, J.O. Dynamic TurboFLASH subtraction technique for contrast-enhanced MR imaging of the prostate: correlation with histopathologic results. Radiology 1997 Jun, 203(3), 645–652.
   PubMed Web of Science ®Google Scholar
• Wefer, A.E.; Hricak, H.; Vigneron, D.B.; Coakley, F.V.; Lu, Y.; Wefer, J.; Mueller-Lisse, U.; Carroll, P.R.; Kurhanewicz, J. Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology. J Urol 2000 Aug, 164(2), 400–404.
   PubMed Web of Science ®Google Scholar
• Testa, C.; Schiavina, R.; Lodi, R.; Salizzoni, E.; Corti, B.; Farsad, M.; Kurhanewicz, J.; Manferrari, F.; Brunocilla, E.; Tonon, C.; Monetti, N.; Castellucci, P.; Fanti, S.; Coe, M.; Grigioni, W.F.; Martorana, G.; Canini, R.; Barbiroli, B. Prostate cancer: sextant localization with MR imaging, MR spectroscopy, and 11C-choline PET/CT. Radiology 2007 Sep, 244(3), 797–806.
   PubMed Web of Science ®Google Scholar
• Fütterer, J.J.; Heijmink, S.W.; Scheenen, T.W.; Veltman, J.; Huisman, H.J.; Vos, P.; Hulsbergen-Van de Kaa, C.A.; Witjes, J.A.; Krabbe, P.F.; Heerschap, A.; Barentsz, J.O. Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging. Radiology 2006 Nov, 241(2), 449–458.
   PubMed Web of Science ®Google Scholar
• Palapattu, G.S.; Sutcliffe, S.; Bastian, P.J.; Platz, E.A.; De Marzo, A.M.; Isaacs, W.B.; Nelson, W.G. Prostate carcinogenesis and inflammation: emerging insights. Carcinogenesis 2005 Jul, 26(7), 1170–1181.
   PubMed Web of Science ®Google Scholar
• Noworolski, S.M.; Vigneron, D.B.; Chen, A.P.; Kurhanewicz, J. Dynamic contrast-enhanced MRI and MR diffusion imaging to distinguish between glandular and stromal prostatic tissues. Magn Reson Imaging 2008, 26(8), 1071–1080.
   PubMed Web of Science ®Google Scholar